CN Stock MarketDetailed Quotes

600993 Mayinglong Pharmaceutical Group

Watchlist
  • 25.62
  • +0.29+1.14%
Market Closed Nov 4 15:00 CST
11.04BMarket Cap22.90P/E (TTM)

Mayinglong Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mayinglong Pharmaceutical Group Q3 2024 Earnings Date

Currency：CNYOct 26, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
864.10M
--
+7.22%
Net Income
--
148.52M
--
+8.63%
Analyst Rating
Strong Buy

Nov 4, 2024

Mayinglong Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Apr 27, 20192019/Q1609.963M / 587.679M--
DatePeriodRevenue/EstimateEarnings Call
Apr 27, 20192019/Q1609.963M / 587.679M--

Mayinglong Pharmaceutical Group Earnings Reports

  • Ma Yinglong Report for the Third Quarter of 2024

    Oct 25 12:00 ET

  • Mayinglong Pharmaceutical Group's 2024 semi-annual report

    Aug 23 12:00 ET

  • Summary of Mayinglong Pharmaceutical Group's 2024 semi-annual report

    Aug 23 12:00 ET

  • Ma Yinglong's 2024 First Quarter Report

    Apr 19 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 4, 2024

    Strong Buy

    • Strong Buy

      85.71%

    • Buy

      14.29%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data